Starch, Corn
drugOn this page
Also known as Corn starchCorn starch (pregelatinized)pregelatinizedCornstarchKoiMaize starchPregelatinized corn starch 1551Starch 1500Starch 1500 pregelatinizedStarch 1551Starch maize pregelatinizedStarchcornStarch, corn (spress b820)corn component of ntx-1 corn starchmaizepregelatinized cornSuperstarch 200Topical starchUni-pure fl
Summary
Starch, Corn (CHEMBL2108052) is a phase-3 clinical-stage unknown; indicated across 2 conditions including type 1 diabetes mellitus.
At a glance
- Status: Max clinical phase 3 (not approved)
- Modality: Unknown
- Indications: 2 conditions
- Clinical trials: 24
Identifiers
Drug identity and classification
| Field | Value |
|---|---|
| ChEMBL ID | CHEMBL2108052 |
| Name | Starch, Corn |
| Type | Unknown |
| Max phase | 3 |
Also known as: Corn starch, Corn starch (pregelatinized), pregelatinized, Cornstarch, Koi, Maize starch, Pregelatinized corn starch 1551, Starch 1500, Starch 1500 pregelatinized, Starch 1551, Starch maize pregelatinized, Starch
Targets
Targets
No target linkage available.
Bioactivity
No ChEMBL bioactivity rows at pChembl ≥ 5 (expected for biologics / antibodies).
Target pathways
No target-pathway data for this drug (no mapped target genes).
Indications & clinical
Indications
2 indications (0 at ChEMBL trial phase 4). Phase below is the highest clinical-trial phase recorded for this drug against each disease — not the molecule’s overall approval status (that is in the Summary).
| Indication | Trial phase | MONDO | EFO |
|---|---|---|---|
| type 1 diabetes mellitus | 3 | MONDO:0005147 | MONDO:0005147 |
1 further indication record had no mapped disease name (EFO/MeSH-only) or were duplicates, and are omitted.
Clinical trials
Total trials: 24.
Phase distribution
| Phase | Trials |
|---|---|
| Not specified | 13 |
| PHASE2 | 4 |
| PHASE4 | 3 |
| PHASE2/PHASE3 | 2 |
| PHASE3 | 1 |
| PHASE1 | 1 |
Top trials by phase / activity
| NCT | Phase | Status | Title |
|---|---|---|---|
| NCT00700557 | PHASE4 | COMPLETED | Probiotics at the Treatment of Antibiotic Associated Diarrhea |
| NCT00828178 | PHASE4 | COMPLETED | Efficacy of Fish Oil in Lupus Patients |
| NCT01391468 | PHASE4 | COMPLETED | Beneficial Effect of Probiotics on Chronic Kidney Disease |
| NCT00346333 | PHASE3 | COMPLETED | Clinical Trial of Lutein for Patients With Retinitis Pigmentosa Receiving Vitamin A |
| NCT02516475 | PHASE2/PHASE3 | COMPLETED | Effects of Zinc Supplementation on Anthropometric Factors, Apelin and Inflammatory Markers in Obese Individuals |
| NCT04710290 | PHASE2/PHASE3 | UNKNOWN | A Cohort Study of Beta-Glucan or Beta-Glucan Compound in Metastatic Cancers |
| NCT00728221 | PHASE2 | COMPLETED | Evaluation and Standardization of Ginseng and it’s Components for Blood Pressure Regulation |
| NCT00730951 | PHASE2 | COMPLETED | The Evaluation and Standardization of Ginseng and Its Components for Blood Pressure Regulation |
| NCT02794922 | PHASE2 | COMPLETED | Effectiveness of Vitamin B in Reducing Temporomandibular Joint Disorder Pain |
| NCT06315699 | PHASE2 | COMPLETED | Clemastine Fumarate in the Treatment of Neurodevelopmental Delays in Williams Syndrome |
| NCT01045395 | PHASE1 | COMPLETED | Efficacy of Two Algae Formulations on Lipid Metabolism, Inflammation and Oxidative Stress Status in Individuals With Psoriasis |
| NCT06692361 | Not specified | RECRUITING | Assessment of the Efficacy and Safety of Fecal Microbiota Transplantation (FMT) in Patients With Major Depressive Disorder |
| NCT06900946 | Not specified | ENROLLING_BY_INVITATION | Evaluation of the Effects of Gluten Free Diet on Clinical Symptoms and Glycemic Index in Type 2 Diabetic Patients With Non-celiac Gluten Sensitivity |
| NCT00561288 | Not specified | COMPLETED | Effects of Acetaminophen on Hurt Feelings |
| NCT01186276 | Not specified | COMPLETED | Dietary Maneuvers to Reduce Production of Colon-Derived Uremic Solutes |
| NCT02006394 | Not specified | COMPLETED | Novel Dietary Interventions for Treating Insulin Resistance |
| NCT02351089 | Not specified | TERMINATED | Probiotics in Radiation-treated Gynecologic Cancer |
| NCT03352856 | Not specified | SUSPENDED | Food Challenge With Barley Starch as Active Comparator |
| NCT03871673 | Not specified | COMPLETED | The Use of Uncooked Sweet Manioc Starch to Treat Hepatic Glycogen Storage Diseases |
| NCT04961164 | Not specified | COMPLETED | Resistant Starch Prebiotic Effects in Chronic Kidney Disease |
| NCT05941650 | Not specified | UNKNOWN | To Study the Effect of Short-chain Fructooligosaccharides in Women With Irritable Bowel Syndrome |
| NCT05980520 | Not specified | COMPLETED | Study on the Treatment of Taurine in Children With Autism |
| NCT05995522 | Not specified | COMPLETED | Effect of Vitamin K2 Over Osteocalcin, Leptin, Cytokines, and Cardiovascular Risk in Young Adults With Overweight and Obesity |
| NCT07343219 | Not specified | SUSPENDED | Effects of Root Extract Ashwagandha (KSM-66) on Physiological Stress, Perception of Recovery and Muscle Strength in Youth Footballers |
Clinical evidence (CIViC)
No CIViC predictive evidence (expected for non-precision-medicine drugs).
Pharmacology
Pharmacogenomics
No PharmGKB pharmacogenomic data curated for this drug.
Related molecules
Related molecules
No competitor molecules sharing a primary target (ChEMBL phase ≥2 or PubChem drug-class).
Related Atlas pages
- Diseases: type 1 diabetes mellitus